Product NDC: | 0168-0258 |
Proprietary Name: | Clotrimazole and Betamethasone Dipropionate |
Non Proprietary Name: | Clotrimazole and Betamethasone Dipropionate |
Active Ingredient(s): | .5; 10 mg/g; mg/g & nbsp; Clotrimazole and Betamethasone Dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0258 |
Labeler Name: | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075502 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010605 |
Package NDC: | 0168-0258-15 |
Package Description: | 15 g in 1 TUBE (0168-0258-15) |
NDC Code | 0168-0258-15 |
Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
Package Description | 15 g in 1 TUBE (0168-0258-15) |
Product NDC | 0168-0258 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20010605 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Substance Name | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE |
Strength Number | .5; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |